Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

NCT01447043 · clinicaltrials.gov ↗

COMPLETED

Status

2609

Enrollment

INDUSTRY

Sponsor class

Conditions

Ophthalmology, Macular Degeneration

Interventions

DRUG: Ranibizumab

Sponsor

Bayer